353 related articles for article (PubMed ID: 26364188)
21. Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy.
Hininger I; Waters R; Osman M; Garrel C; Fernholz K; Roussel AM; Anderson RA
Free Radic Biol Med; 2005 Jun; 38(12):1565-70. PubMed ID: 15917185
[TBL] [Abstract][Full Text] [Related]
22. EDTA chelation therapy for cardiovascular disease: a systematic review.
Seely DM; Wu P; Mills EJ
BMC Cardiovasc Disord; 2005 Nov; 5():32. PubMed ID: 16262904
[TBL] [Abstract][Full Text] [Related]
23. EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.
Lamas GA; Boineau R; Goertz C; Mark DB; Rosenberg Y; Stylianou M; Rozema T; Nahin RL; Terry Chappell L; Lindblad L; Lewis EF; Drisko J; Lee KL
Am Heart J; 2014 Jul; 168(1):37-44.e5. PubMed ID: 24952858
[TBL] [Abstract][Full Text] [Related]
24. A TACTful reappraisal of chelation therapy in cardiovascular disease.
Sidhu MS; Saour BM; Boden WE
Nat Rev Cardiol; 2014 Mar; 11(3):180-3. PubMed ID: 24343569
[TBL] [Abstract][Full Text] [Related]
25. Evaluation on curative effects of ethylene diamine tetra-acetic acid chelation therapy in treating with atherosclerotic cardiovascular disease: A protocol for systematic review and meta-analysis.
Song T; Zhang D
Medicine (Baltimore); 2020 Dec; 99(52):e23346. PubMed ID: 33350725
[TBL] [Abstract][Full Text] [Related]
26. EDTA chelation therapy meets evidence-based medicine.
Lamas GA; Hussein SJ
Complement Ther Clin Pract; 2006 Aug; 12(3):213-5. PubMed ID: 16835033
[No Abstract] [Full Text] [Related]
27. The protection conferred by chelation therapy in post-MI diabetics might be replicated by high-dose zinc supplementation.
McCarty MF; DiNicolantonio JJ
Med Hypotheses; 2015 May; 84(5):451-5. PubMed ID: 25682188
[TBL] [Abstract][Full Text] [Related]
28. Chelation therapy after the trial to assess chelation therapy: results of a unique trial.
Avila MD; Escolar E; Lamas GA
Curr Opin Cardiol; 2014 Sep; 29(5):481-8. PubMed ID: 25023079
[TBL] [Abstract][Full Text] [Related]
29. Heavy Metal Toxicity in Chronic Renal Failure and Cardiovascular Disease: Possible Role for Chelation Therapy.
Glicklich D; Shin CT; Frishman WH
Cardiol Rev; 2020; 28(6):312-318. PubMed ID: 32040019
[TBL] [Abstract][Full Text] [Related]
30. Design of the Trial to Assess Chelation Therapy (TACT).
Lamas GA; Goertz C; Boineau R; Mark DB; Rozema T; Nahin RL; Drisko JA; Lee KL
Am Heart J; 2012 Jan; 163(1):7-12. PubMed ID: 22172430
[TBL] [Abstract][Full Text] [Related]
31. Chelation therapy for cardiovascular disease. Review and commentary.
Lewin MR
Tex Heart Inst J; 1997; 24(2):81-9. PubMed ID: 9205980
[No Abstract] [Full Text] [Related]
32. Environment and cardiovascular health: causes, consequences and opportunities in prevention and treatment.
Bañeras J; Iglesies-Grau J; Téllez-Plaza M; Arrarte V; Báez-Ferrer N; Benito B; Campuzano Ruiz R; Cecconi A; Domínguez-Rodríguez A; Rodríguez-Sinovas A; Ujueta F; Vozzi C; Lamas GA; Navas-Acién A
Rev Esp Cardiol (Engl Ed); 2022 Dec; 75(12):1050-1058. PubMed ID: 35931285
[TBL] [Abstract][Full Text] [Related]
33. MY APPROACH to the use of chelation therapy.
Lamas GA
Trends Cardiovasc Med; 2016 Aug; 26(6):583-4. PubMed ID: 27199091
[No Abstract] [Full Text] [Related]
34. By the way, doctor. I get mail extolling the virtues of chelation therapy. The claim is that it removes calcium and other metals from the walls of arteries. The key element appears to be EDTA. Since vinegar is also primarily acetic acid, I'm curious whether it could have the same effect.
Komaroff AL
Harv Health Lett; 2004 Mar; 29(5):8. PubMed ID: 15044137
[No Abstract] [Full Text] [Related]
35. Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
Elihu N; Anandasbapathy S; Frishman WH
J Clin Pharmacol; 1998 Feb; 38(2):101-5. PubMed ID: 9549639
[TBL] [Abstract][Full Text] [Related]
36. Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?
Lamas GA; Ergui I
Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):927-38. PubMed ID: 27149141
[TBL] [Abstract][Full Text] [Related]
37. Role of EDTA chelation therapy in cardiovascular diseases.
Shrihari JS; Roy A; Prabhakaran D; Reddy KS
Natl Med J India; 2006; 19(1):24-6. PubMed ID: 16570682
[TBL] [Abstract][Full Text] [Related]
38. From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.
National Heart, Lung, and Blood Institute
Ethn Dis; 2013; 23(3):388. PubMed ID: 23914432
[No Abstract] [Full Text] [Related]
39. Enhanced vasculotoxic metal excretion in post-myocardial infarction patients following a single edetate disodium-based infusion.
Arenas IA; Navas-Acien A; Ergui I; Lamas GA
Environ Res; 2017 Oct; 158():443-449. PubMed ID: 28689036
[TBL] [Abstract][Full Text] [Related]
40. Chelation therapy for ischemic heart disease: a randomized controlled trial.
Knudtson ML; Wyse DG; Galbraith PD; Brant R; Hildebrand K; Paterson D; Richardson D; Burkart C; Burgess E;
JAMA; 2002 Jan 23-30; 287(4):481-6. PubMed ID: 11798370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
